3. STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Stock-based compensation costs	$ 125,675	$ 141,033
Unrecognized compensation costs related to options vesting	0
Aggregate intrinsic value of "in the money" outstanding	40,980
Aggregate intrinsic value of "in the money" exercisable	$ 30,200
Investors
Common stock sold, shares issued	1,717,152
Proceeds from sale of stock	$ 1,030,291
Warrants
Warrants outstanding	3,270,444
Warrant weighted average exercise price	$ 1.12
Warrants | June 2008
Warrant weighted average exercise price	$ 1.03
Warrants authorized for issuance	493,398
Warrants | September 2012
Warrant weighted average exercise price	$ 1.11
Warrants authorized for issuance	2,189,724
Warrants | September 2012-2
Warrant weighted average exercise price	$ 0.85
Warrants authorized for issuance	217,322
2011 Plan
Shares authorized for issuance under the plan	1,825,000
Stock options outstanding	889,102
Shares available for future grants	968,596
2006 Plan
Shares authorized for issuance under the plan	139,898
Stock options outstanding	139,898
Shares available for future grants	0
1997 Plan
Stock options outstanding	50,079
Shares available for future grants	0
Stock Options
Options granted	714,000	9,000
Stock options outstanding	1,079,079	409,087	400,087
Selling, General and Administrative Expenses
Stock-based compensation costs	$ 107,300	$ 134,800
Cost of Goods Sold
Stock-based compensation costs	0	4,033
Research and Development Expenses
Stock-based compensation costs	$ 18,375	$ 2,200